University of Derby’s Capital Growth Fund Programme has offered Cellomatics a grant to support the purchase of new equipments. This is an extremely encouraging news as the grant funding would further strengthen our CRO capabilities. This grant has been awarded under the European Commission’s De Minimis Regulation (EU) No 1407/2013. This offer of grant is supported by the Ministry for Housing, Communities and Local Government (MHCLG) and the European Regional Development Fund (ERDF).
Our vision has always been to constantly strive and add value to the drug discovery services offered to our Clients. Thanks to this funding support from University of Derby’s Capital Growth Fund Programme that is helping us achieve these objectives.